K. Dietzmann et al., IMMUNOHISTOCHEMICAL DETECTION OF VASCULAR GROWTH-FACTORS IN ANGIOMATOUS AND ATYPICAL MENINGIOMAS, AS WELL AS HEMANGIOPERICYTOMAS, Pathology research and practice, 193(7), 1997, pp. 503-510
The arachnoideal compartment provides the vascular sources for three d
ifferent tumor types rich in vessels: angiomatous meningioma, some aty
pical meningioma with high vascularity and meningeal hemangiopericytom
a. We investigated immunohistochemically the expression and distributi
on of vascular mitogenes in 7 angiomatous meningiomas, 8 atypical meni
ngiomas with high vasculature and 4 hemangiopericytomas. On the one ha
nd it should be studied which vascular growth factors such as VPF/VEGF
-1, VPF/VEGF-2, bFGF, PDGF and TGF-alpha could be responsible for the
close meshwork of vessels within the tumors. On the other hand we were
interested in whether or not there are differences in vascular mitoge
ns between slowly growing angiomatous meningiomas and both other types
with their increased tendency to recur. PDGF and TGF-alpha were exten
sively expressed in the endothelium and smooth muscle cells of the ves
sels, as well as tumor cells. VEGF-2 could only be found in endothelia
l cells of all three tumor entities. bFGF was localized in some vessel
s of angiomatous meningiomas and VEGF-1 revealed a very low expression
with a localization comparable with VEGF-2. Moreover, uPAR was diffus
ely expressed in nearly all tumor cells and endothelial cells. The fac
t that tumor cells of hemangiopericytomas and meningiomas did not show
any immunohistochemical reaction with VEGF's could indicate a lower p
riority of these growth factors for neovascularization in this type of
neoplasm. A different expression of vascular mitogens between benign
angiomatous meningiomas and atypical meningiomas as well as hemangiope
ricytomas with their tendency for recurrence could not be observed. Th
e morphological evidence for extravasates of IgG-proteins, Fibrin and
Fibronectin due to VPF-effects seems not to be a renouncable condition
for neoangiogensis in the tumors investigated.